MEMCover: integrated analysis of mutual exclusivity and functional network reveals dysregulated pathways across multiple cancer types
暂无分享,去创建一个
Teresa M. Przytycka | Yoo-Ah Kim | Dong-Yeon Cho | Phuong Dao | Dong-Yeon Cho | Phuong Dao | T. Przytycka | Y. Kim
[1] J. Horsfield,et al. Gene Regulation by Cohesin in Cancer: Is the Ring an Unexpected Party to Proliferation? , 2011, Molecular Cancer Research.
[2] Eli Upfal,et al. Discovery of Mutated Subnetworks Associated with Clinical Data in Cancer , 2011, Pacific Symposium on Biocomputing.
[3] M. Newman,et al. On the uniform generation of random graphs with prescribed degree sequences , 2003, cond-mat/0312028.
[4] S. Gabriel,et al. High-throughput oncogene mutation profiling in human cancer , 2007, Nature Genetics.
[5] S. Gabriel,et al. Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.
[6] C. Sander,et al. Mutual exclusivity analysis identifies oncogenic network modules. , 2012, Genome research.
[7] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[8] Teresa M. Przytycka,et al. Chapter 5: Network Biology Approach to Complex Diseases , 2012, PLoS Comput. Biol..
[9] Benjamin J. Raphael,et al. Pan-Cancer Network Analysis Identifies Combinations of Rare Somatic Mutations across Pathways and Protein Complexes , 2014, Nature Genetics.
[10] Eli Upfal,et al. Algorithms for Detecting Significantly Mutated Pathways in Cancer , 2010, RECOMB.
[11] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[12] Niko Beerenwinkel,et al. Modeling Mutual Exclusivity of Cancer Mutations , 2014, RECOMB.
[13] Julie M. Sahalie,et al. Supplementary Figure and Table Legends , 2022 .
[14] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[15] Nam Jin Yoo,et al. Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors , 2013, International journal of cancer.
[16] A. Sivachenko,et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. , 2011, The New England journal of medicine.
[17] Peifang Liu,et al. Functional SNP in the microRNA-367 binding site in the 3′UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification , 2011, Proceedings of the National Academy of Sciences.
[18] Chris Sander,et al. Using MEMo to Discover Mutual Exclusivity Modules in Cancer , 2013, Current protocols in bioinformatics.
[19] Masao Nagasaki,et al. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms , 2012, Nature Genetics.
[20] Steven J. M. Jones,et al. Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.
[21] Benjamin J. Raphael,et al. De novo discovery of mutated driver pathways in cancer , 2011 .
[22] Benjamin J. Raphael,et al. Mutational landscape and significance across 12 major cancer types , 2013, Nature.
[23] Teresa M. Przytycka,et al. Module Cover - A New Approach to Genotype-Phenotype Studies , 2012, Pacific Symposium on Biocomputing.
[24] Roded Sharan,et al. Simultaneous Identification of Multiple Driver Pathways in Cancer , 2013, PLoS Comput. Biol..
[25] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[26] Haiyuan Yu,et al. HINT: High-quality protein interactomes and their applications in understanding human disease , 2012, BMC Systems Biology.
[27] Steven J. M. Jones,et al. Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.